Skip to main content
OpenTrials

Clinical trial condition

Metastatic Pancreatic Ductal Adenocarcinoma

Explore clinical trials studying Metastatic Pancreatic Ductal Adenocarcinoma. Study availability and eligibility vary by location and protocol.

42 public trials 15 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Pancreatic Ductal Adenocarcinoma trial results

Completed

A Study of Botensilimab in Participants With Metastatic Pancreatic Cancer

NCT05630183

Conditions
Metastatic Pancreatic Ductal Adenocarcinoma
Locations
  • HonorHealth Scottsdale, Arizona, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • USC Norris Oncology Newport Beach, California, United States
  • UCLA Health - Santa Monica Cancer Care Santa Monica, California, United States
View all 36 locations
View Trial Details
Completed

Study of Efficacy and Safety of NIS793 in Combination With Standard of Care (SOC) Chemotherapy in First-line Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) - daNIS-2

NCT04935359

Conditions
Metastatic Pancreatic Ductal Adenocarcinoma
Locations
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • University of California LA Los Angeles, California, United States
  • AdventHealth Orlando, Florida, United States
  • Fort Wayne Medical Oncology Hematology Inc Fort Wayne, Indiana, United States
View all 113 locations
View Trial Details
Completed

EF-39 PANOVA-4: Study of Tumor Treating Fields Concomitant With Atezolizumab, Gemcitabine and Nab-Paclitaxel as First-LineTreatment for Metastatic Pancreatic Ductal Adenocarcinoma

NCT06390059

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • University Hospital Hradec Kralove Hradec Králové, Czechia
  • University Hospital Olomouc Olomouc, Czechia
  • University Hospital Motol Prague, Czechia
  • University Hospital Bulovka Prague, Czechia
View all 15 locations
View Trial Details
Completed

A Study of ERAS-007 in Patients With Advanced Gastrointestinal Malignancies

NCT05039177

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +14 more
Locations
  • University of Alabama at Birmingham (O'Neal Comprehensive Cancer Center) Birmingham, Alabama, United States
  • City of Hope Duarte, California, United States
  • University of California Irvine College of Medicine Orange, California, United States
  • UCSF Mount Zion Medical Ctr San Francisco, California, United States
View all 14 locations
View Trial Details
Completed

Study Evaluating the Ketogenic Diet in Patients With Metastatic Pancreatic Cancer

NCT04631445

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Honor Health Scottsdale, Arizona, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Nuvance Health-Danbury Hospital Danbury, Connecticut, United States
  • Nuvance Health Norwalk, Connecticut, United States
View Trial Details
Completed

A Study of the Safety and Tolerance of CAN04 in Combination With FOLFIRINOX in Subjects With Metastatic Pancreatic Ductal Adenocarcinoma

NCT04990037

Conditions
Adenocarcinoma, Carcinoma, Digestive System Diseases, +14 more
Locations
  • EDOG - Institut Bergonie - PPDS Bordeaux, France
  • EDOG Institut de Cancerologie de l'Ouest - PPDS Nantes, France
  • EDOG - Centre Eugene Marquis Centre Regional de Lutte Contre Le Cancer - PPDS Rennes, France
  • Institut de Cancerologie de l'Ouest Saint-Herblain, France
View Trial Details

Related conditions